ResearcherUniversity of MissouriNo recent work listed

Hao Wu

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0001-6154-9759; OpenAlex author ID A5053261559. Sources: OpenAlex.

Their work

Papers: 2 (first author 0, last author 1)
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 3

Papers, trials and grants by year

2022: 1 paper · 2023: 1 paper

Papers 2

Proteasome-dependent senescent tumor cells mediate immunosuppression through CCL20 secretion and M2 polarization in pancreatic ductal adenocarcinoma. Co-author DOI 10.3389/fimmu.2023.1216376 ↗
Diaphanous-related formin subfamily: Novel prognostic biomarkers and tumor microenvironment regulators for pancreatic adenocarcinoma. Last author DOI 10.3389/fmolb.2022.910950 ↗

Closest collaborators

The 3 strongest of 3 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Mengwei Wu · 1 shared paper, 2023 · strength 0.26
- Paper Proteasome-dependent senescent tumor cells mediate immunosuppression through CCL20 secretion and M2 polarization in pan… DOI 10.3389/fimmu.2023.1216376 ↗
Ziwen Liu · 1 shared paper, 2023 · strength 0.26
- Paper Proteasome-dependent senescent tumor cells mediate immunosuppression through CCL20 secretion and M2 polarization in pan… DOI 10.3389/fimmu.2023.1216376 ↗
Bixi Zhang · 1 shared paper, 2022 · strength 0.16
- Paper Diaphanous-related formin subfamily: Novel prognostic biomarkers and tumor microenvironment regulators for pancreatic a… DOI 10.3389/fmolb.2022.910950 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.